New blood test could quickly predict if the drug palbociclib will help breast cancer patients

A new study has found a blood test for cancer DNA could predict if a woman is responding to the breast cancer drug palbociclib, months earlier than current tests. Scientists say the test could detect in two to three weeks whether the drug is working.
Source: Medical Research Council General News - Category: Research Source Type: news